Trial reportScientific reports2025
A healthy lifestyle education intervention for metabolic syndrome risk reduction among office workers in Ethiopia: a single-blind, randomised controlled trial.
Trial report in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The increasing prevalence of metabolic syndrome among office workers in Ethiopia underscores the urgent need for tailored health interventions. This study aimed to implement a healthy lifestyle education intervention designed to reduce the prevalence of metabolic syndrome and evaluate changes in participants' knowledge and attitudes regarding metabolic syndrome, cardiovascular diseases, and risk factors, as well as improvements in healthy lifestyle practices. This 9-month institution-based, single-masked, cluster-randomised controlled trial was conducted among bank employees in Bahir Dar. A total of 226 participants were screened based on waist circumference and blood pressure. The intervention was a personalised educational program focused on lifestyle modifications, delivered by health promotion experts, while the control group received general health advice based on the guidelines on clinical and programmatic management of major NCDs. Outcomes were assessed at baseline and after 9 months, with 207 participants included in the final analysis using an intention-to-treat approach, and generalised estimating equations to assess the intervention's effect between groups. The intervention group exhibited significant improvements, with decreases in waist circumference (5.33 cm), systolic blood pressure (6.96 mmHg), diastolic blood pressure (4·21 mmHg), total cholesterol (34.12 mg/dL), and low- density lipoprotein cholesterol (20·68 mg/dl) (all p < 0.0001). Knowledge scores increased by 7.29 points, fruit intake rose from 0.74 to 1.21 portions, and vegetable intake grew from 1.10 to 1.77 portions. Participation in moderate exercise rose from 29.52% to 53.33%. In contrast, the control group showed modest improvements in some components of metabolic syndrome risk factors. However, there were no significant changes in triglycerides, fasting blood glucose, and stress management, while high density lipoprotein cholesterol levels unfavorably declined in both groups. This study highlighted the impact of a tailored workplace-based healthy lifestyle education intervention on lifestyle behaviors and metabolic syndrome risk factors. The intervention led to positive changes in several behaviors and reduced some risk factors. However, it did not significantly improve triglyceride and fasting blood glucose levels, and there was an unexpected decrease in high density lipoprotein cholesterol. This unexpected decrease of high-density lipoprotein cholesterol may result from lifestyle shifts, including reduced fatty diet intake and rapid weight loss, and other metabolic adaptation process. Future research should focus on targeted strategies and long-term interventions to address these unexpected outcomes.Trial registration: ACTRN12623000409673p, registered April 24, 2023 and is completed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.